Molecular Therapeutics for Heritable Skin Diseases

Journal of Investigative Dermatology

Volumn 132, Issue , 2012, Pages E29-E34

  Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE THERAPY; GENETIC DISORDER; GENETICS; HUMAN; METHODOLOGY; REVIEW; SKIN DISEASE; STEM CELL TRANSPLANTATION;

GENETIC DISEASES, INBORN; GENETIC THERAPY; HUMANS; SKIN DISEASES; STEM CELL TRANSPLANTATION;

EID: 84879690707     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/skinbio.2012.9     Document Type: Article

References (48)

1. Agarwal, S., Loh, Y.H., McLoughlin, E.M., et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464 (2010), 292–296.
2. Badiavas, E.V., Abedi, M., Butmarc, J., et al. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 196 (2003), 245–250.
3. Bruckner-Tuderman, L., Has, C., Molecular heterogeneity of blistering disorders: the paradigm of epidermolysis bullosa. J Invest Dermatol 132 (2012), E2–E5.
4. Bruckner-Tuderman, L., McGrath, J.A., Robinson, E.C., et al. Animal models of epidermolysis bullosa: update 2010. J Invest Dermatol 130 (2010), 1485–1488.
5. Chen, Y.Q., Mauviel, A., Ryynanen, J., et al. Type VII collagen gene expression by human skin fibroblasts and keratinocytes in culture: influence of donor age and cytokine responses. J Invest Dermatol 102 (1994), 205–209.
6. Chino, T., Tamai, K., Yamazaki, T., et al. Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 173 (2008), 803–814.
7. Conget, P., Rodriguez, F., Kramer, S., et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 12 (2010), 429–431.
8. De Luca, M., Pellegrini, G., Mavilio, F., Gene therapy of inherited skin adhesion disorders: a critical overview. Br J Dermatol 161 (2009), 19–24.
9. Feramisco, J.D., Sadreyev, R.I., Murray, M.L., et al. Phenotypic and genotypic analyses of genetic skin disease through the Online Mendelian Inheritance in Man (OMIM) database. J Invest Dermatol 129 (2009), 2628–2636.
10. Fine, J.D., Eady, R.A., Bauer, E.A., et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58 (2008), 931–950.
11. Fujita, Y., Abe, R., Inokuma, D., et al. Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice. Proc Natl Acad Sci USA 107 (2010), 14345–14350.
12. Gostynski, A., Deviaene, F.C., Pasmooij, A.M., et al. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy. Br J Dermatol 161 (2009), 444–447.
13. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302 (2003), 415–419.
14. Howden, S.E., Gore, A., Li, Z., et al. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci USA 108 (2011), 6537–6542.
15. Intong, L.R., Murrell, D.F., Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol 30 (2012), 70–77.
16. Itoh, M., Kiuru, M., Cairo, M.S., et al. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci USA 108 (2011), 8797–8802.
17. Jonkman, M.F., Scheffer, H., Stulp, R., et al. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 88 (1997), 543–551.
18. Kaspar, R.L., McLean, W.H., Schwartz, M.E., Achieving successful delivery of nucleic acids to skin: 6th Annual Meeting of the International Pachyonychia Congenita Consortium. J Invest Dermatol 129 (2009), 2085–2087.
19. Kern, J.S., Loeckermann, S., Fritsch, A., et al. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther 17 (2009), 1605–1615.
20. Kiuru, M., Itoh, M., Cairo, M.S., et al. Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa. Dermatol Clin 28 (2010), 371–382.
21. Lai-Cheong, J.E., McGrath, J.A., Uitto, J., Revertant mosaicism in skin: natural gene therapy. Trends Mol Med 7 (2011), 140–148.
22. Leachman, S.A., Hickerson, R.P., Schwartz, M.E., et al. First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 18 (2010), 442–446.
23. Li, Q., Frank, M., Thisse, C.I., et al. Zebrafish: a model system to study heritable skin diseases. J Invest Dermatol 131 (2011), 565–571.
24. Mavilio, F., Pellegrini, G., Ferrari, S., et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12 (2006), 1397–1402.
25. McLean, W.H., Hansen, C.D., Eliason, M.J., et al. The phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol 131 (2011), 1015–1017.
26. McLean, W.H., Moore, C.B., Keratin disorders: from gene to therapy. Hum Mol Genet 20 (2011), R189–R197.
27. Nagy, N., Almaani, N., Tanaka, A., et al. HBEGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 131 (2011), 1771–1774.
28. Natsuga, K., Shinkuma, S., Nishie, W., et al. Animal models of epidermolysis bullosa. Dermatol Clin 28 (2010), 137–142.
29. Pasmooij, A.M., Jonkman, M.F., First symposium on natural gene therapy of the skin. Exp Dermatol 21 (2012), 236–239.
30. Petrova, A., Ilic, D., McGrath, J.A., Stem cell therapies for recessive dystrophic epidermolysis bullosa. Br J Dermatol 163 (2010), 1149–1156.
31. Remington, J., Wang, X., Hou, Y., et al. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 17 (2009), 26–33.
32. Siprashvili, Z., Nguyen, N.T., Bezchinsky, M.Y., et al. Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue. Hum Gene Ther 21 (2010), 1299–1310.
33. Smith, F.J.D., Hickerson, R.P., Sayers, J.M., et al. Development of therapeutic siRNAs for pachyonychia congenita. J Invest Dermatol 128 (2008), 50–58.
34. Stanley, J.R., Rubinstein, N., Klaus-Kovtun, V., Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. J Invest Dermatol 85 (1985), 542–545.
35. Tamai, K., Kaneda, Y., Uitto, J., Molecular therapies for heritable blistering diseases. Trends Mol Med 15 (2009), 285–292.
36. Titeux, M., Pendaries, V., Zanta-Boussif, M.A., et al. SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther 18 (2010), 1509–1518.
37. Tolar, J., Blazar, B.R., Wagner, J.E., Concise review: transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa. Stem Cells 29 (2011), 900–906.
38. Tolar, J., Ishida-Yamamoto, A., Riddle, M., et al. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 113 (2009), 1167–1174.
39. Tolar, J., Xia, L., Riddle, M.J., et al. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 131 (2011), 848–856.
40. Uitto, J., Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies. Acta Derm Venereol 89 (2009), 228–235.
41. Uitto, J., Cell-based therapy for RDEB: how does it work?. J Invest Dermatol 131 (2011), 1597–1599.
42. Uitto, J., Regenerative medicine for skin diseases: iPS cells to the rescue. J Invest Dermatol 131 (2011), 812–814.
43. Uitto, J., Christiano, A.M., McLean, W.H., et al. Novel molecular therapies for heritable skin disorders. J Invest Dermatol 132 (2012), 820–828.
44. Wagner, J.E., Ishida-Yamamoto, A., McGrath, J.A., et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 363 (2010), 629–639.
45. Wong, T., Gammon, L., Liu, L., et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128 (2008), 2179–2189.
46. Woodley, D.T., Krueger, G.G., Jorgensen, C.M., et al. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J Invest Dermatol 121 (2003), 1021–1028.
47. Yan, W.F., Murrell, D.F., Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa. Dermatol Clin 28 (2010), 367–370.
48. Uitto, J., Molecular therapeutics for heritable skin diseases. J Invest Dermatol 132 (2012), E29–E34.